These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713. Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and cardiac effects of two novel beta-adrenoceptor blocking drugs. Scriabine A; Ludden CT; Morgan G; Baldwin JJ Experientia; 1979 Dec; 35(12):1634-7. PubMed ID: 42553 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol. Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the hypotensive action of prazosin. Constantine JW; McShane WK; Scriabine A; Hess HJ Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141 [TBL] [Abstract][Full Text] [Related]
7. Tiamenidine (Hoe 440), a new antihypertensive substance. Lindner E; Kaiser J Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):305-25. PubMed ID: 4460920 [No Abstract] [Full Text] [Related]
8. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol. Watkins RW; Sybertz EJ; Cook J; Pula K; Cedeno K; Tedesco RP; McLeod R Arch Int Pharmacodyn Ther; 1989; 302():158-73. PubMed ID: 2576892 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems. Hirohashi M; Takasuna K; Yamashita N; Tamura K Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150 [TBL] [Abstract][Full Text] [Related]
11. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137 [TBL] [Abstract][Full Text] [Related]
12. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent. Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410 [No Abstract] [Full Text] [Related]
13. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects. Collis MG; Keddie JR; Rouse W Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224 [TBL] [Abstract][Full Text] [Related]
14. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines. Buschmann G; Kühl UG; Rohte O Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761). Sweet CS; Scriabine A; Weitz D; Ludden CT; Minsker DH; Stone CA J Pharmacol Exp Ther; 1979 Oct; 211(1):200-6. PubMed ID: 114619 [No Abstract] [Full Text] [Related]
16. Substituted aryl-tetrahydro-pyrrolo imidazoles: a new class of centrally acting antihypertensives [proceedings]. Clough DP; Hatton R; Pettinger SJ; Samuels GM; Shaw A Br J Pharmacol; 1978 Mar; 62(3):385P-386P. PubMed ID: 638323 [No Abstract] [Full Text] [Related]
17. Animal experiments on the cardiovascular effects of lofexidine. Graf E; Doppelfeld IS; Prop G Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator. Baldoli E; Bianchi G; Corsico N; Di Francesco GF Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874 [TBL] [Abstract][Full Text] [Related]
19. Some cardiovascular effects of ST-91 and clonidine. Scriabine A; Sweet CS; Ludden CT; Stavorski JM; Wenger HC; Bohidar NR Eur J Pharmacol; 1977 Jun; 43(4):333-41. PubMed ID: 18355 [TBL] [Abstract][Full Text] [Related]